Literature DB >> 9786925

Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53.

H Y Tang1, K Zhao, J F Pizzolato, M Fonarev, J C Langer, J J Manfredi.   

Abstract

The tumor suppressor protein p53 has been implicated in the response of cells to DNA damage. Studies to date have demonstrated a role for p53 in the transcriptional activation of target genes in the cellular response to DNA damage that results in either growth arrest or apoptosis. In contrast, here is demonstrated a role for p53 in regulating the basal level of expression of the cyclin-dependent kinase inhibitor p21 in the absence of treatment with DNA-damaging agents. Wild-type p53-expressing MCF10F cells had detectable levels of p21 mRNA and protein, whereas the p53-negative Saos-2 cells did not. Saos-2 cells were infected with recombinant retrovirus to establish a proliferating pool of cells with a comparable constitutive level of expression of wild-type p53 protein to that seen in untreated MCF10F cells. Restoration of wild-type but not mutant p53 expression recovered a basal level of expression of p21 in these cells. Constitutive expression of luciferase reporter constructs containing the p21 promoter was inhibited by co-transfection with the human MDM2 protein or a dominant-negative p53 protein and was dependent on the presence of p53 response elements in the reporter constructs. Furthermore, p53 in nuclear extracts of untreated cells was capable of binding to DNA in a sequence-specific manner. These results implicate a role for p53 in regulating constitutive levels of expression of p21 and demonstrate that the p53 protein is capable of sequence-specific DNA binding and transcriptional activation in untreated, proliferating cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786925     DOI: 10.1074/jbc.273.44.29156

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis.

Authors:  B C McKay; F Chen; C R Perumalswami; F Zhang; M Ljungman
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo.

Authors:  M Doubrovin; V Ponomarev; T Beresten; J Balatoni; W Bornmann; R Finn; J Humm; S Larson; M Sadelain; R Blasberg; J Gelovani Tjuvajev
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  Role for p53 in the recovery of transcription and protection against apoptosis induced by ultraviolet light.

Authors:  B C McKay; M Ljungman
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

4.  Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.

Authors:  S Nakamura; J A Roth; T Mukhopadhyay
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.

Authors:  Kyrie Pappas; Jia Xu; Sakellarios Zairis; Lois Resnick-Silverman; Francesco Abate; Nicole Steinbach; Sait Ozturk; Lao H Saal; Tao Su; Pamela Cheung; Hank Schmidt; Stuart Aaronson; Hanina Hibshoosh; James Manfredi; Raul Rabadan; Ramon Parsons
Journal:  Mol Cancer Res       Date:  2017-05-08       Impact factor: 5.852

6.  Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer.

Authors:  Xiao Ling Li; Murugan Subramanian; Matthew F Jones; Ritu Chaudhary; Deepak K Singh; Xinying Zong; Berkley Gryder; Sivasish Sindri; Min Mo; Aaron Schetter; Xinyu Wen; Swetha Parvathaneni; Dickran Kazandjian; Lisa M Jenkins; Wei Tang; Fathi Elloumi; Jennifer L Martindale; Maite Huarte; Yuelin Zhu; Ana I Robles; Susan M Frier; Frank Rigo; Maggie Cam; Stefan Ambs; Sudha Sharma; Curtis C Harris; Mary Dasso; Kannanganattu V Prasanth; Ashish Lal
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

7.  The Meq oncoprotein of Marek's disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  Xufang Deng; Xiangdong Li; Yang Shen; Yafeng Qiu; Zixue Shi; Donghua Shao; Yamei Jin; Hongjun Chen; Chan Ding; Li Li; Puyan Chen; Zhiyong Ma
Journal:  Virol J       Date:  2010-11-26       Impact factor: 4.099

8.  Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.

Authors:  Vladimir N Ivanov; Hongning Zhou; Tom K Hei
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

9.  A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097.

Authors:  Sébastien Jeay; Swann Gaulis; Stéphane Ferretti; Hans Bitter; Moriko Ito; Thérèse Valat; Masato Murakami; Stephan Ruetz; Daniel A Guthy; Caroline Rynn; Michael R Jensen; Marion Wiesmann; Joerg Kallen; Pascal Furet; François Gessier; Philipp Holzer; Keiichi Masuya; Jens Würthner; Ensar Halilovic; Francesco Hofmann; William R Sellers; Diana Graus Porta
Journal:  Elife       Date:  2015-05-12       Impact factor: 8.140

10.  Knockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition.

Authors:  Sivakamasundari Pichu; Swapna Krishnamoorthy; Andrei Shishkov; Bi Zhang; Peter McCue; Biddanda C Ponnappa
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.